Outsourcing

Aug 01, 2018
Pharmaceutical Technology
Why shouldn’t biopharmaceutical manufacturers be able to leverage standardized construction practices to improve time to market?
Aug 01, 2018
Pharmaceutical Technology
Heightened uncertainty means CDMO executives need to play out planning scenarios.
Aug 01, 2018
Pharmaceutical Technology
This article provides a sampling of the latest investments, expansions, and acquisitions by small-molecule contract service providers.
Aug 01, 2018
Pharmaceutical Technology
CMOs have been active over the past year in expanding their biologics production and capabilities.
Aug 01, 2018
Pharmaceutical Technology
API can be mixed with silicone and other polymers to create drug-delivery combination products.
Jul 27, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
Quartzy, an online laboratory supply management company, will offer lab products from Bioline, Biotium, and MP Biomedicals.
Jul 24, 2018
By Pharmaceutical Technology Editors
The glass and chemical provider will expand its synthetic pharmaceutical intermediate and API production capacity at its plant in Chiba, Japan.
Jul 24, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
The API and drug product provider will invest £375,000 (US$493,000) in additional nuclear magnetic resonance (NMR) instrumentation at its headquarters in Craigavon, UK.
Jul 23, 2018
By Pharmaceutical Technology Editors
The acquisition will place Cambrex into the finished dosage form CDMO market.
Jul 18, 2018
By Pharmaceutical Technology Editors
CELLforCURE will produce cancer CAR-T treatments for Novartis at a manufacturing facility in Les Ulis (Essonne), France.
native1_300x100
lorem ipsum